Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 645 items.
Unauthorized products may pose serious health risks
Health Canada is advising about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as "…
AlertPublic advisory | 2023-01-25
Unauthorized health products removed from sale from More to Shoppe Facebook store and seized from its Edson, Alberta, warehouse
Health Canada removed various unauthorized health products from sale from More to Shoppe, an online Facebook store, and seized them from its warehouse in Edson, Alberta. The products are labelled to contain prescription drugs and may pose serious health…
AlertPublic advisory | 2023-01-20
RUZURGI (amifampridine) - Authorization Status
UPDATED INFORMATION – January 20, 2023
On January 10, 2023, following a Federal Court of Appeal decision, the June 24, 2021 decision of the Minister of Health on the application of the data protection provisions was restored, and a new Notice of…
AlertHealth professional risk communication | 2023-01-20
Belzer MPS and Belzer UW: Particulate matter
Presence of particulate matter in affected lot.
RecallHealth product recall | 2023-01-18
99.0 % Oxygen USP - Gas cylinders containing commercial grade oxygen
Gas cylinders containing commercial grade oxygen instead of medical grade oxygen were delivered to homecare customers.
RecallHealth product recall | 2022-12-22
18F-Fludeoxyglucose (18F-FDG); Sterility concerns
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
NAT-Bendamustine: Discoloration
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
OCALIVA received a Notice of Compliance with Conditions in May 2017 for the treatment of PBC, pending the results of trials to verify its clinical benefit.
OCALIVA is now contraindicated for PBC patients with advanced disease, such as those with Child…
AlertHealth professional risk communication | 2022-12-05
Privigen: Series of adverse reactions
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
Teva-Atenolol; Product label image incorrect
Affected lot has incorrect product image on the product label.
RecallHealth product recall | 2022-11-21
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
The Canadian labelling for all Janus Kinase (JAK) inhibitors is being updated to include the risks of serious heart-related problems, fatal blood clots and cancer. This is being done as a precautionary measure. To date, Canadian labelling for the drugs…
AlertPublic advisory | 2022-11-01
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
The final results of a clinical trial conducted with XELJANZ showed higher risks of MACE, thrombosis, malignancy, serious infections and fatal events, compared to TNFi, a group of medicines that suppress the body's natural response to tumor necrosis…
AlertHealth professional risk communication | 2022-10-31
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
Children’s ibuprofen/acetaminophen shortage: What you should know and do
Since earlier this year, supplies of various formats of non-prescription pediatric/infant and children’s acetaminophen and ibuprofen products have been limited in retail and pharmacy locations and hospitals across Canada. This shortage is due to…
AlertPublic advisory | 2022-10-07
Menopur: Potential for a future out of specification result during shelf life
Potential for a future out of specification result during shelf-life
RecallHealth product recall | 2022-09-28